Although not an Israeli treatment, Israel’s Sheba Medical Center is one of the few global hospitals treating prostate cancer patients with Lutetium-177 therapy. It attaches to prostate-specific membrane antigens (PSMAs) on tumors and emits beta radiation to neutralize them.

https://www.shebaonline.org/how-does-lutetium-177-therapy-work/